Stem Cell Therapy for COPD
Regenerative cellular therapy protocol supporting lung tissue repair
In COPD stem cell therapy, mesenchymal stem cells derived from the patient's own body are administered intravenously. These cells suppress inflammation and support repair of damaged lung tissue. Still in the investigational phase, this treatment may be considered as an additional option for patients who have not responded adequately to standard therapies.
Who Is a Candidate?
Suitable Candidates
- ✓ GOLD Stage 2-4 stable COPD
- ✓ Inadequate response to standard therapies
- ✓ Former smoker
- ✓ No serious active infection or malignancy
Not Eligible
- ✗ Active infection
- ✗ Active malignancy
- ✗ Coagulation disorder
- ✗ Immunosuppressive therapy
How the Procedure Works
Benefits & Expected Outcomes
- Reduction in inflammation
- Increased exercise capacity in some patients
- Offered in addition to standard therapies
Risks & Complications
⚠️ As with any medical procedure, there are risks. The following is evidence-based information.
- • Transient fever/chills
- • Reaction risk (low)
- • Long-term efficacy evidence is limited
Stem cell therapy for COPD is one of the most exciting developments in regenerative medicine in recent years. While conventional treatments (inhalers, oxygen, etc.) only aim to control symptoms, stem cell therapy targets the repair of damaged lung tissue and stopping chronic inflammation at the cellular level.
1. Anti-Inflammatory Effect
COPD involves unstoppable chronic inflammation in the lungs. Mesenchymal Stem Cells (MSCs) migrate toward inflammatory areas in the lungs after being introduced to the body (the "homing" mechanism).
- •Blocking the Cytokine Storm: Stem cells suppress the production of harmful cytokines (inflammatory proteins) in the lungs.
- •Immune Modulation: By "calming" the immune system, they slow damage to lung parenchyma.
2. Alveolar Repair and Tissue Regeneration
In emphysema, the main problem is the breakdown of air sacs (alveoli).
- •Paracrine Effect: Stem cells secrete growth factors that encourage neighboring healthy cells to repair themselves.
- •Angiogenesis: They improve blood flow in damaged areas, enhancing tissue nutrition.
3. Clinical and Functional Gains
- •Increased Exercise Tolerance: The patient can walk longer distances.
- •Reduced Breathlessness: Breathing improves as airway edema is reduced at the cellular level.
- •Decreased Exacerbation Frequency: The risk of infection-related hospitalization decreases.
Important Clinical Note
Stem cell therapy is still in "clinical research" or "approved experimental treatment" status in many countries.
- •Safety: When cells are derived from your own tissue (autologous), the risk of allergy or rejection is negligible.
Recovery Process
Tests Required for Evaluation
Upload the following documents in your Free Evaluation form for remote candidacy assessment:
- ✓ Complete blood count
- ✓ Spirometry
- ✓ 6MWT
- ✓ Bone marrow or adipose tissue suitability assessment
- ✓ Monthly blood gas values and DLCO test results
Compare Your Options
| Feature | Investigational (Stem Cell) | Endobronchial Valve | Coil |
|---|---|---|---|
| Mechanism | Regeneration | Mechanical | Mechanical |
| Incision | None | None | None |
| FDA Approval Detail | — | FDA APPROVED | NOT FDA APPROVED (EU/CE Approved) |
Patient Experience
I was told I wasn't suitable for other treatments. Six months after stem cell therapy, my breathlessness noticeably improved.
Frequently Asked Questions
Scientific References
Got a question before deciding?
Our coordinator is on WhatsApp, ready to help.
Next Treatment
NUSS Procedure (Pectus Excavatum)
Minimally invasive bar correction technique for pectus excavatum